SCHEMBL18371997

SCHEMBL18371997

CCCc1ccc(-c2ccc(OCC)c(F)c2F)cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 6/20 0.43
GABRB2 P47870 6/20 0.43
FGFR2 P21802 2/20 0.40
FGFR1 P11362 1/20 0.40
CTSL P07711 1/20 0.40
CTSS P25774 1/20 0.40
CTSK P43235 1/20 0.40
S1PR1 P21453 5/20 0.39
S1PR3 Q99500 2/20 0.37
PTPRC P08575 1/20 0.36
ALOX5 P09917 1/20 0.36
PPARD Q03181 1/20 0.35
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22809285 0.87 GABRA1 (0.44) GABRA1GABRB2FGFR2FGFR1CTSL
SCHEMBL10303391 0.85 CTSS (0.49) GABRA1GABRB2FGFR2FGFR1CTSL
SCHEMBL16852421 0.83 CTSL (0.45) GABRA1GABRB2FGFR2FGFR1CTSL
SCHEMBL8932327 0.82 NAAA (0.42) GABRA1GABRB2FGFR2FGFR1CTSL
SCHEMBL12579513 0.81 CTSS (0.56) GABRA1GABRB2FGFR2FGFR1CTSL
SCHEMBL10301920 0.80 CTSL (0.44) GABRA1GABRB2FGFR2FGFR1CTSL
SCHEMBL12579528 0.80 CNR2 (0.41) GABRA1GABRB2FGFR2FGFR1CTSL
SCHEMBL6889160 0.79 GABRA1 (0.43) GABRA1GABRB2FGFR2FGFR1CTSL
SCHEMBL10302027 0.79 GABRA1 (0.43) GABRA1GABRB2FGFR2FGFR1CTSL
SCHEMBL10303278 0.78 NAAA (0.44) GABRA1GABRB2FGFR2FGFR1CTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9896427-B2 Liquid crystal composition and liquid crystal display including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-02-20 US disclosed
US-9896427-B2 Liquid crystal composition and liquid crystal display including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-02-20 US disclosed
US-20170008872-A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-01-12 US disclosed
US-20170008872-A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170008872-A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY INCLUDING THE SAME CALCOCO2, LASP1, NOLC1 GABRA1 3861/4885GABRB2 4151/4885FGFR2 570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.